Table 2a.
Summary (n= 47) | |
---|---|
Malignant | 23 (49%) |
Pancreatic adenocarcinoma | 20 (43%) |
Pancreatic adenocarcinoma de novo | 10 (21%) |
Pancreatic adenocarcinoma with underlying IPMN | 10 (21%) |
Cholangiocarcinoma with IPMN | 1 (2%) |
Neuroendocrine tumour | 1 (2%) |
Renal cell carcinoma | 1 (2%) |
Non-malignant | 24 (51%) |
Non-invasive IPMN | 21 (45%) |
Chronic pancreatitis | 2 (4%) |
Trauma | 1 (2%) |
IPMN, intraductal papillary mucinous neoplasms.